2025

US government has altered more than 100 scientific databases since 20 January

Latest news on US crisis (3 July): legal challenges, Global Fund, WHO, Kigali conference

13th IAS Conference on HIV Science (IAS 2025)

Clinical phase 2/3 studies put on hold for two once-weekly pipeline compounds

UK PrEP 2025 guidelines: reviewed online

Why the new HIV PrEP guidelines from the UK are so exciting (2025)

Latest on US crisis (26 June): Global Fund, GAVI and RFK Jnr

Long-acting injectable PrEP approved in the US: priced at $28,000 a year

Future meetings and webinars 2025

Latest on US crisis (13 June): legal and organisational responses

HIV organisations support trans and non-binary communities against the unworkable EHRC guidance

Featured UK HIV care for transgender and non-binary people: EHRC guidance is unworkable

Kigali Call to Action: sign-on for IAS 2025 conference

UK guidelines on doxyPEP to prevent syphilis and gonorrhoea vaccine to become available in England

APBI calls for greater participant diversity in industry studies 

Risk of metabolic syndrome when starting ART with bictegravir vs dolutegravir

TAG challenges HIV vaccine cuts as Robert F. Kennedy fires entire CDC vaccine expert advisory panel

Gates Foundation commits to providing lenacapavir as PrEP next year

Featured Latest news on the US crisis and its impact on global health

IAS-USA update drug resistance mutations (2025)

Vaccination is effective in limiting mpox progression – but lower efficacy in people living with HIV

US updates guidelines for statin use in people living with HIV

HIV activists in the US call for action in JID and Zachie Achmat brings South African perspective in the Lancet

Combining injectable lenacapavir and cabotegravir-LA

Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement

Impact of US funding cuts in Malawi and South Africa: ITPC community report

The Denver Principles – riso print by Jane Shepherd to support i-Base

US CDC updated guidelines on PEP (May 2025)

Featured Reduced dosing: a possible crisis response to ART stockouts and closed clinics

Closed clinics and limited ART in Zimbabwe, PEPFAR and UNAIDS news

Yellow card reporting scheme for doctors and patients in the UK

The RIO study: Q&A about controlling HIV with bNAbs

Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years

CROI 2025: Webcasts and other resources now open access

Continued reports from CROI 2025

Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs

CROI 2025: LAPTOP, EC rebounds after 32 years, two more HSCT cures

Lancet Commission on gender justice and equality

Changes to US policy jeopardises the lives of 500,000 children living with HIV by 2030

CROI 2025: Rebecca Denison gives opening community talk on 40 years of HIV

Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care

CROI 2025: BHIVA best of CROI feedback now online

People living with HIV need two shots of the mpox vaccine and likely a booster after two years

CROI 2025: Two bNAbs enable viral suppression off-ART in African women in the FRESH cohort

Cuts in aid: up to 10 million new HIV infections and almost 3 million related deaths by 2030

Stopping ART safely if your clinic is closed or runs out of meds: a practical guide

Webinar on stopping ART if your clinic is closed: practical facts on safety and risk

CROI 2025: Introduction to this year’s conference

CROI 2025: RIO study: Dual-bNABs keep viral load undetectable off-ART – plus a potential first case of vaccine-like HIV remission

CROI 2025: Switching to daily fixed-dose doravirine/islatravir: two randomised phase 3 studies

CROI 2025: Tecovirimat has no benefit against mpox in STOMP study

CROI 2025: Ensitrelvir significantly reduces risk of developing COVID-19 after household exposure

CROI 2025: N6LS: 4-monthly injectable bNAb with monthly injectable cabotegravir

Summary of Australian guidelines for anal cancer screening in people living with HIV

CROI 2025: Reducing Biktarvy from daily to only once, twice or three times a week

CROI 2025: Potential for once-yearly lenacapavir injections

CROI 2025: Delegates send open letter to protest US cuts

CROI 2025: Stand Up For Science rally against Trump funding freeze

HIV and vaccine denialist is proposed to head the US NIH: further alarm for global science

Global update: 90-day review ended early and cancelled 10,000 grants, millions of people will suffer

Responses to the UK government slashing international aid by 40%

Deleted words from official documents: LGBTQ, diversity, inclusion, transgender

Country update from Nigeria: current impact on HIV services

Semaglutide reduces alcohol and cigarette use in a randomised phase 2 study

News and resources linked to changes in US policy on international aid

Post navigation